Fujiyama Power Systems — small-town solar's branded assembler
Fujiyama Power Systems Ltd
Snapshot
Fujiyama Power Systems sells complete rooftop-solar kits — the panel, the inverter and the battery, all under one roof and one brand — to households and small businesses in India’s smaller towns and villages. Its brands, “UTL Solar” and “Fujiyama Solar”, have been around for nearly 30 years, and it reaches the customer through a network of roughly 8,200 channel partners (about 725 distributors, ~5,500–6,800 dealers, and ~1,100 franchise “UTL Solar Shoppe” outlets). It listed on the exchanges on 20 November 2025.
Market cap ₹9,545 cr, share price ₹311 (up ~36% from its ₹228 IPO price; 52-week range ₹388 / ₹171). The screener page shows a P/E of 483 — ignore that number, it’s computed on stale FY2020–21 data. On the real, just-reported FY26 earnings (PAT ₹304 cr), the stock trades at about 31× trailing and ~20× on FY27 guidance. As of 2026-06-20, from the screener snapshot + the May-2026 FY26 results.
What kind of animal it is: a Good business — fast-growing, well-run, with a genuine but narrow distribution moat — that is capital-hungry and has a commodity (solar-panel) core. It is not a Buffett-style asset-light franchise, and it is riding an unusually favourable policy moment.
The bottom line
| Lens | Result |
|---|---|
| QGLP score (Motilal Oswal) | 16.5 / 25 — Quality 7/12 · Growth 5.5/6 · Longevity 3/5 · Price 1/2 |
| Buffett rubric | ~3.5 / 10 PASS-equivalent (fails the franchise / asset-light / predictability bars) |
| Business bucket | Good — healthy returns, but needs heavy capital to grow; commodity panel core |
| Wealth-creator type | Enduring demand, Transitory returns · Consistency untestable (only ~3–4 yrs of P&L, 7 months listed) |
| Economic Profit | ≈ +₹200 cr (ROE ~28% est. − CoE 12% on ~₹1,250 cr net worth) — creating value today, but the spread is partly a policy rent |
| Margin-of-safety price band | ₹220–₹265 (≈15–18× FY27e earnings, allowing for cyclicality + narrow moat). CMP ₹311 is demanding — it prices in flawless execution, and is ~2.5× its closest twin’s multiple |
A Good, well-run, fast-growing business that is a real wealth creator right now — but priced rich versus the quality and versus its nearest peer, with returns that the industry’s own history says will normalise downward.
In plain English
Imagine the shop in a small Indian town that, for thirty years, has sold you your inverter and your battery when the power went out. Now the same shop sells you a full solar setup — panel on the roof, inverter on the wall, battery in the corner — and it all carries one familiar name and one phone number to call when something breaks. That, in one sentence, is Fujiyama. It isn’t a solar-panel factory pretending to be a brand; it’s a branded, dealer-sold consumer-power business that happens to make a lot of its own parts. About 60% of what it sells is the sticky, branded stuff (inverters and batteries) and about 40% is the panel — the bit that behaves like a commodity.
The business is booming, and the boom is real. Revenue went from ₹925 cr (FY24) to ₹1,541 cr (FY25) to ₹2,654 cr in FY26, and profit nearly doubled last year to ₹304 cr. The wind at its back is government policy: the PM Surya Ghar rooftop-subsidy scheme, rules that force solar projects to use Indian-made cells (ALMM and “DCR”), and stiff import duties that keep Chinese panels out. Fujiyama just spent ₹300 cr building its own solar-cell plant at Dadri so it can supply those scarce, premium “domestic-content” cells in-house — which fattens its margins nicely. So far, smart.
Here’s the tension. The moat is real but shallow. Its dealer network is genuine and took years to build — but it is roughly one-tenth the size of Luminous’s (70,000+ dealers, owned by Schneider) and smaller than Microtek’s and Exide’s, all of whom sell the exact same panel-inverter-battery bundle to the exact same customer. And the juicy margin from scarce domestic cells is, by management’s own admission, partly passed back to customers — it’s rent on a temporary shortage that the whole industry is racing to fill, not a wall nobody can climb. Every business in India that has done what Fujiyama does well — Exide, Amara Raja — has settled, over time, at low-teens returns on equity. Fujiyama earns far more than that today. The honest base case is that today’s supernormal returns are a young-company, policy-boom peak, not a plateau.
So the one-line verdict: a good business having a great moment, run by people who execute fast — but you’re being asked to pay ~31× earnings (and ~7–8× book) for it, when its closest listed twin, Insolation Energy, trades at under 13×. The quality is real; the price assumes the moment lasts.
Sitting down with the management
If Buffett and Raamdeo Agrawal sat across from Pawan Kumar Garg, they’d find a lot to like — and a few things to watch.
Who built it. Mr Garg founded UTL Electronics in 1996 and spent three decades turning a small-town inverter brand into a solar systems company; his co-promoter and CEO, Yogesh Dua, has ~28 years in power electronics (Sunil Kumar is the third promoter). This is the good kind of promoter — an operator who knows the product, the dealer, and the village customer cold, not a financier assembling assets. The whole company is an extension of a genuine, three-decade obsession with backup power for places where the grid is unreliable. That’s exactly the “passion + domain mastery” Buffett looks for.
How they’ve spent the owners’ money. The execution record is the strongest part of the story. They built the Dadri 1 GW solar-cell line in about six months, for ~₹300 cr against a ~₹400 cr budget — faster and cheaper than peers who ordered equipment a year earlier. The ₹828 cr IPO (₹600 cr fresh + ₹228 cr the promoters sold) was put to sensible use: ~₹180 cr into the Ratlam plant, ₹275 cr to pay down debt, the rest for general purposes. They deliberately chose a cheaper, faster Mono-PERC cell line over pricier TOPCon to hit the 2026 demand window — and then hedged that bet by approving a 1.2 GW TOPCon line (May 2026) for the next cycle. That is thoughtful, sequenced capital allocation, not empire-building. The one-dollar test (does each retained rupee create a rupee of value?) passes so far — but the record is short, and they pay no dividend yet, so the test is provisional.
Do they talk straight? Mostly yes. The concalls (hosted by Motilal Oswal) are candid on operations and they admit what they don’t know (“quantify at this stage is very difficult”). But they deliberately withhold segment-wise volume detail “because competition is watching closely” — defensible, but it’s narrative-management you should note. Guidance-versus-delivery, in their seven months as a listed company, has been good: they guided and delivered the Dadri commissioning and strong margins.
The red flags — and they do fire, mildly. Three to keep on the radar: (1) screener flags that the company “might be capitalising the interest cost” — i.e. parking some interest expense on the balance sheet rather than running it through the P&L; for a company building plants this can be legitimate, but it flatters reported profit and deserves a look in the annual report. (2) A BIS (Bureau of Indian Standards) search-and-seizure at the Noida facility in March 2026 over ~10–15 of ~500 SKUs (mainly inverters/batteries); management says BIS certification wasn’t mandatory on those items and expects no material impact — unresolved, legal process pending. (3) A significant fire at the Bawal (Haryana) lead-acid battery plant on 6 May 2026 (1.3 GWh capacity, suspended); no injuries, fully insured, third-party arrangements activated. None of these is fatal, but for a company this young they’re a reminder that the operational and governance machinery is still being battle-tested.
Skin in the game and minorities. Promoter holding is 86.8% and steady since listing (no selling after the IPO — good). The flip side: a ~87% promoter stake means a tiny free float and minority holders along for the ride on whatever the family decides. No pledging surfaced in available sources (verify in the annual report).
Would Buffett and Agrawal shake hands? Probably a guarded yes on the people — competent, hungry, domain-obsessed operators with a clean-enough record and a real execution edge. The thing that would change their mind: any sign the interest-capitalisation flag is hiding strain, or that the BIS/quality issues point to a culture cutting corners as it scales. Verdict: trustworthy operators, short track record — watch the accounting honesty as the capex ramps.
What’s on the horizon (live-issues tracker)
Four threads will decide the next one-to-three years.
1 — THE CRUX: Is the moat a wall or a rented fence? 🟡
This investment works if and only if Fujiyama’s small-town distribution + brand stays sticky and its returns don’t collapse to the industry’s low-teens norm as the policy rent fades.
The mechanism, in plain terms. Fujiyama’s defenders point to three moats. Test each:
- The dealer/brand network — real, but it’s a head start, not exclusivity. Think of the local Luminous inverter dealer: customers trust the brand and the service number, and switching is a hassle. That stickiness is genuine. But the people who own the deepest version of that exact moat — Luminous, Microtek, Exide — are 5–10× bigger on dealer count and sell the identical solar bundle. Fujiyama wins today on focus, a clever twin-brand trick (two brands = two dealers per town), and pure-play hunger — none of which is a wall an incumbent can’t climb.
- Backward integration into DCR cells — a true cost edge (in-house domestic-content cells reportedly lift gross margin sharply) — but management openly says it’ll pass part of that margin to customers, and it’s rent on a cell shortage the whole industry is building capacity to erase.
- The one-stop integrated bundle — convenient, but Luminous, Microtek, Livguard, Exide and Servotech all sell it too. Table-stakes, not a moat.
The precedent — this is the decisive evidence. Look at what happened to the durable Indian consumer-power brands: Exide’s return on capital slid from ~24% (FY15–18) to ~9% (FY26); Amara Raja’s from 23% to 12%. Even the winners of the branded-dealer-power business commoditised to low-teens returns; Su-Kam, once a #1 inverter brand, went bankrupt (NCLT, 2017–19). Meanwhile the pure solar-panel makers (the commodity analogy) live and die on policy: Chinese top-4 makers lost ~$1.5 bn in H1 2025 selling below cost; Indian makers’ fat margins (Premier Energies’ OPM went 4–5% → 30%) are explicitly protection-driven. Fujiyama looks like the branded-dealer business (Precedent A) with a commodity-panel core (Precedent B) — and Precedent A already tells you where ~37% ROE ends up.
The named threat map:
| Rival | Backing | Dealer reach | Threat to Fujiyama |
|---|---|---|---|
| Luminous | Schneider Electric | 70,000+ dealers | #1 — deepest network, global balance sheet, building solar |
| Exide | Listed (EXIDEIND) | 120,000+ partners, 18,000+ rural; solar arm > ₹1,000 cr FY26 | Largest rural reach; “Exide Sunday” turnkey kits |
| Microtek | Private | 100,000+ dealers | Full stack, largest dealer count, opaque financials |
| Livguard | SAR Group | 10,000+ dealers | Aggressive on subsidy biz, but financially weak (downgraded 2025) |
| Servotech | Listed (SERVOTECH) | Smaller, building | Closest listed pure-play to Fujiyama’s lane, far smaller |
| Deye / Growatt (China) | Global | OEM/white-label | Pressures the inverter line-item; a Fujiyama dealer may already sell a rebadged Deye |
Honest read: narrow moat — real but shallow, and partly rented. Not “no moat,” not “too hard to call.” It’s a good business riding an exceptional moment. The ~37% ROE is almost certainly a peak, not a plateau. 🟡 mixed — the niche is genuine but the returns are not structurally protected.
2 — The DCR-cell / ALMM policy super-cycle 🟢 (but watch the air-pocket)
ALMM List-II (the approved-list for cells) goes live 1 June 2026, forcing subsidy/government projects to use domestic cells — and approved domestic cell capacity (~30 GW) is far below module capacity (~100–120 GW), so integrated players who self-supply cells are structurally favoured. DCR cells command a large premium (the domestic shortage). This is genuine rocket fuel and Fujiyama is positioned right. The yellow flag: PM Surya Ghar new registrations were paused from 6 June 2026 (1.38 cr registrations received vs the 1-crore target; ~59 lakh processed) — possibly a target-met reset, possibly a demand air-pocket. Verify the MNRE notification. 🟢 trajectory strong, one thing to watch.
3 — The Ratlam 2 GW build-out 🟡 (early)
A ₹272 cr (ex-land) integrated plant (module + inverter + lithium) at Ratlam, with first revenue from Q1 FY27 and full utilisation targeted by Q4 FY28. Management guides this roughly doubles capacity and could roughly double revenue at full utilisation (₹5,000 cr peak). It’s the engine behind the “+50% FY27 revenue” guidance. 🟡 too early — first lines only ramping; watch utilisation prints.
4 — Mono-PERC obsolescence risk 🟡 (mitigated)
Globally, Mono-PERC cells have collapsed to ~10% of new shipments as the world moves to TOPCon. Fujiyama deliberately built PERC (cheaper, faster, fits the 2026 window). The de-riskers: India’s price-sensitive residential market still defaults to cheaper PERC; the subsidy rules are technology-agnostic; a PERC line is retrofittable to TOPCon for ~$0.08–0.10/W; and they’ve already approved a separate TOPCon line for FY28. Treat Dadri as a 2–3 year cash cow with an upgrade option, not a 10-year asset. The real risk is wafer supply drying up for the legacy PERC SKU — directional, not yet a 2026 event. 🟡 manageable, well-sequenced.
The watch-list (check these next quarter)
- DCR gross-margin trend — does the headline integration margin hold, or start compressing as domestic cell capacity floods in? (The single most important number.)
- PM Surya Ghar — is the 6-June-2026 registration pause a reset or a demand cliff? Watch monthly installation data.
- Ratlam utilisation — first prints from Q1 FY27; is it ramping on the guided curve?
- Off-grid → on-grid mix — is Fujiyama converting its backup-power dealers to grid-tied solar before the off-grid niche shrinks?
- Operating cash flow vs PAT — does the ₹304 cr profit actually turn into cash, or does working capital + the interest-capitalisation flag keep OCF soft? (Forensic check.)
- BIS case + Bawal fire — resolution and any P&L hit.
QGLP scorecard (the Motilal Oswal lens) — the receipts
| # | Question (plain meaning) | Score | Evidence |
|---|---|---|---|
| Q1 | Large opportunity? | 1 | Rooftop solar ~40–45% CAGR; India 300 GW solar by 2030; PM Surya Ghar 1-cr-homes target. Huge runway. |
| Q2 | Industry structured well? | 0.5 | Fragmented, commoditising panel core, intense competition from bigger incumbents; margins improving but partly policy-driven. |
| Q3 | Defensible moat? | 0.5 | Real but narrow distribution/brand moat; out-scaled ~10:1 by Luminous/Microtek/Exide. High RoE but only ~3 yrs of public record. |
| Q4 | Return ratios >15%? | 1 | FY25 ROE high-30s%, ROCE mid-30s% (IPO note); clearly >15%. (Screener’s 58%/16.6% are stale FY20-21 figures.) Durability unproven. |
| Q5 | Asset-light? | 0 | Capital-hungry: ₹300 cr Dadri + ₹272 cr Ratlam + ₹350 cr TOPCon; historically negative operating & free cash flow. Fails the See’s test. |
| Q6 | Favourable terms of trade (neg. working capital)? | 0 | Debtor ~41d ≈ payable ~44d, but inventory ~85d → positive working capital that must be funded. Not an FMCG-style cash engine. |
| Q7 | Integrity / clean accounts? | 0.5 | ”Might be capitalising interest” flag; BIS seizure (contested); plant fire (insured). No pledging surfaced. Minor flags fire. |
| Q8 | Proven execution? | 1 | Dadri built in 6 months for ₹300 cr vs ₹400 cr budget; revenue ~3× in two years; margins delivered. |
| Q9 | Growth mindset / vision? | 1 | Backward integration, twin-brand strategy, capacity doubling, on-grid push. Clear ambition matched by action. |
| Q10 | Superior capital allocation? | 0.5 | Reinvests at high RoE; sensible IPO use (capex + debt paydown); no value-destroying M&A — but short record, no dividend. |
| Q11 | Succession plan? | 0.5 | Two promoters + professional CEO/CFO; still key-man on founders. |
| Q12 | Minority interests protected? | 0.5 | Stable 86.8% promoter stake (no post-IPO selling), but tiny float; interest-capitalisation flag; no payout yet. |
| Q13 | Structural tailwind? | 1 | Rooftop solar growing far faster than GDP; policy super-cycle. |
| Q14 | Volume-led growth? | 1 | Panels 255→460 MW (9M), inverters 508→900 MW; growth is volume + integration, not price. |
| Q15 | Operating leverage? | 1 | EBITDA margin expanded 15.5% → 18.7% (Q3) as revenue scaled. |
| Q16 | Manageable leverage? | 1 | Debt ~₹470 cr, ₹275 cr repaid from IPO; comfortable now. |
| Q17 | Market-share gain potential? | 0.5 | Gaining in rooftop, but out-scaled by incumbents who could press the same customer. |
| Q18 | Earnings growth >15%? | 1 | PAT +94.5% FY26; +50% revenue guided FY27; multi-year visible. |
| Q19 | Relevant for 10–15 yrs (low disruption)? | 0.5 | Solar demand durable, but tech (PERC→TOPCon) + commodity + policy dependence. |
| Q20 | Extend competitive-advantage period? | 0.5 | Narrow moat; returns likely normalise toward industry norm. |
| Q21 | Sustain growth-advantage period? | 1 | Long runway — low rooftop penetration, large TAM. |
| Q22 | Diversification headroom? | 0.5 | New geographies, twin-brand, nascent exports (~2.5%). |
| Q23 | Adaptive culture? | 0.5 | Fast execution, “CAPA” discipline — but unproven through a down-cycle. |
| Q24 | Reasonable valuation (PEG)? | 0.5 | P/E ~31× trailing; PEG ~0.7 on near-term growth — but growth will decelerate and is cyclical/policy-led. |
| Q25 | Margin of safety? | 0.5 | PEG < 1 passes near-term, but 5-yr payback ~2.7× fails. Mixed. |
| Total | 16.5 / 25 | Quality 7/12 · Growth 5.5/6 · Longevity 3/5 · Price 1/2 |
The pattern: Growth is the standout (5.5/6) and Price just about holds (PEG < 1 on near-term numbers). The soft pillar is Quality (7/12) — the moat is narrow, the business is capital-hungry, and the cash conversion is poor. In plain terms: the score is carried by how fast it’s growing and how cheap it looks on forward earnings — not by the durability of the franchise. That’s the profile of a growth/cyclical winner, not a fortress compounder.
Buffett lens (the Berkshire-letters read)
| # | Test | Verdict | Evidence / the Buffett line |
|---|---|---|---|
| 1 | Good boat? (business > management) | PARTIAL | Good, not Great — healthy returns but heavy capital + commodity panel core. “A good managerial record is far more a function of what boat you get into.” |
| 2 | Moat + franchise + pricing power | PARTIAL | Narrow moat; explicitly passes raw-material cost to customers (no pricing power). RoE > CoE, but only ~3 yrs of record. |
| 3 | See’s test — high returns on little capital | FAIL | Heavy capex, historically negative FCF; growth eats cash. The opposite of See’s. |
| 4 | Capital allocation — one-dollar test | PARTIAL | Reinvests at high RoE, sensible IPO use — but too short a record to confirm $1 retained = $1 of value. |
| 5 | Owner-oriented, candid management | PARTIAL | Candid on ops, admits unknowns — but withholds segment data “due to competition.” |
| 6 | Integrity / forensic (no “credit P&L, debit B/S”) | PARTIAL | Interest-capitalisation flag + historically soft operating cash vs profit. Watch OCF/PAT. |
| 7 | Circle of competence / predictability | FAIL | Tech-fragile (PERC→TOPCon), commodity-exposed, policy-dependent. “If there’s lots of technology, we won’t understand it.” |
| 8 | Mr. Market — gift or trap now? | PARTIAL | ~31× trailing / ~20× forward; up 36% from IPO; ~2.5× its closest twin’s multiple. Not euphoric, not a gift. |
| 9 | Patience / compounding runway | PARTIAL | Long TAM runway — but RoE durability at scale is the open question. |
| 10 | The honest red flag | (see below) | mandatory paragraph |
Score: ~3.5 / 10 PASS-equivalent. By Buffett’s strict standard this isn’t in the temple — but read that correctly: it’s not a knock on the company’s quality as a growing business, it’s that Buffett’s tests (asset-light franchise, 10-year predictability, pricing power, cash gushing without capital) are designed to exclude exactly this kind of capital-hungry, commodity-touched, policy-cycle manufacturer, however well-run.
The See’s test, spelled out. See’s Candy needed almost no new capital to grow and gushed cash. Fujiyama is the mirror image: to grow it must keep pouring money into cell lines and module plants (₹300 cr + ₹272 cr + ₹350 cr in a single cycle), and in its earlier years it consumed cash (operating cash flow ran negative). That’s the signature of a Good business, not a Great one — you can make money in it, but the business doesn’t fund its own growth.
The one-dollar test, spelled out. Has each rupee retained created a rupee of value? So far, yes — profits have nearly doubled and the IPO money went to productive capex and debt reduction. But the test needs years to pass honestly, and the more important question is forward: as the company retains earnings to build Ratlam and TOPCon, will those rupees earn the ~30%+ they’ve earned recently, or the low-teens that the mature precedents (Exide, Amara Raja) settled at? The honest answer is lower than today.
Test 10 — the single strongest reason this is NOT a wealth creator: Its supernormal returns are a young-company + policy-rent + boom-demand spike, and the entire Indian history of the branded consumer-power business says they normalise to low-teens ROE over a cycle. Do the numbers refute it? No — they support it. ROCE is already well below ROE (returns are partly leverage-and-rent lifted), cash conversion is weak, and the closest mature analogues all faded. The bull case needs Fujiyama to be the exception, not the rule.
The framework metrics (the working)
- Economic Profit = Net Worth × (RoE − 12%) ≈ ₹1,250 cr × (28% − 12%) ≈ +₹200 cr. Creating value today. (Net worth estimated post-IPO: ~₹400 cr FY25 + ₹600 cr fresh issue + ₹304 cr retained. Using a sustainable ~28% ROE after dilution; on ending equity ROE is ~23%, on average equity ~36%.) Caveat: the +16% spread is partly policy rent — model it fading.
- Terms of Trade = Debtors / Creditors ≈ 93% (≈ neutral) — but with ~85 inventory days, net working capital is positive and must be funded. Not a cash-flow engine.
- 5-yr Payback = Mcap ₹9,545 cr ÷ projected cumulative 5-yr PAT (≈ ₹3,575 cr at 30% PAT CAGR off ₹304 cr) ≈ 2.7×. Fails the < 1× multibagger signal.
- PEG = 31 ÷ ~45 (near-term PAT growth %) ≈ 0.7. Passes < 1 — if the high growth holds; fragile as it decelerates.
- RoE − CoE spread = ~28% − 12% = +16%. RoE > 15% in 3 of 3 public years (FY24–26) — but only ~3–4 years of record exist; the “≥7 of 10” durability test cannot yet be run.
- Consistent vs Volatile (15-yr PAT test): untestable — only ~3–4 years of P&L and 7 months listed. Treat as unproven.
Peer comparison
| Company | Mcap (₹cr) | P/E | P/B | ROE | ROCE | OPM | FY26 Sales (₹cr) | FY26 PAT (₹cr) |
|---|---|---|---|---|---|---|---|---|
| Fujiyama (UTLSOLAR) | 9,545 | ~31 | ~7–8* | ~28–37%* | ~25–35%* | ~18.5% | 2,654 | 304 |
| Insolation Energy (INA) | 2,577 | 12.8 | 3.2 | 28.2% | 22.2% | 13% | 2,146 | 201 |
| Premier Energies | 49,009 | 32.5 | 11.4 | 42.4% | 33.3% | 30% | 7,824 | 1,510 |
| Waaree Energies | 89,903 | 22.9 | 6.2 | 32.8% | 38.8% | 22% | 26,537 | 3,884 |
| Servotech Renewable | 2,296 | 68.4 | 8.0 | 12.8% | 12.8% | 10% | 672 | 32 |
*Fujiyama P/B / return ratios estimated — screener’s public snapshot is stale (FY20-21). Figures from FY25 IPO note + FY26 results.
The read. The right comparison flips the absolute picture. Waaree and Premier are cell/module giants riding the export + DCR supercycle at 22–30% margins — a different, more cyclical animal, and despite their size Waaree trades cheaper (22.9×) than Fujiyama. Servotech is a tiny, low-margin lookalike trading on hope (68×). The truly apples-to-apples peer is Insolation Energy — same integrated-domestic-solar model, similar ₹2,000 cr-ish revenue, similar ROE (28%) — and it trades at 12.8× vs Fujiyama’s ~31×. So on a relative basis, Fujiyama is the most expensive name in its own asset class by a wide margin. Its distinctive edge over Insolation is the longer-established UTL/Fujiyama brand and the bigger dealer franchise — which is worth a premium, but a ~2.5× earnings premium is a steep price for that brand.
Latest quarter & what’s happening now
Q4 FY26 (reported ~15 May 2026): revenue ₹900.8 cr (+87.5% YoY), PAT ₹106.3 cr (+107.5%), EBITDA margin 19.0%. Full-year FY26: revenue ₹2,654 cr (+72.3%), EBITDA ₹490 cr (+97%, 18.5% margin), PAT ₹304 cr (+94.5%, 11.5% margin). Concall takeaways: (1) Dadri 1 GW cell line commissioned and ramping (~65% utilisation, targeting ~80%) — HARD; (2) +50% revenue guidance for FY27, PAT margin 11–13% — MEDIUM; (3) Ratlam contributing from Q1 FY27, full by Q4 FY28 — MEDIUM; (4) Bawal battery plant fire (6 May 2026), suspended, insured — HARD; (5) BIS seizure of 10–15 SKUs being contested — HARD. Management frames raw-material (silver/aluminium) swings as fully pass-through.
Where the two lenses agree — and disagree
They agree on the shape: a fast-growing, well-executed business with a real-but-narrow edge, in a structurally growing market, at a not-cheap price. Both flag the capital intensity (QGLP Q5 = 0, Buffett See’s = FAIL) and the weak cash conversion as the core quality gap.
They diverge sharply on the verdict — and that’s the signal. QGLP scores 16.5/25 (a “strong, two-gaps” business) because the checklist rewards growth and forward-PEG cheapness, which Fujiyama has in spades. Buffett scores it ~3.5/10 because his rubric weights predictability, asset-lightness, pricing power and a decade-long franchise — and on those, a 7-month-listed, capital-hungry, tech-and-policy-exposed solar assembler simply doesn’t qualify. Trust the divergence: it tells you precisely what kind of bet this is. It is a growth/cyclical execution story you might rent for a few years, not a franchise you marry for twenty. Buy it (if at all) for the runway and the momentum, with your eyes open that the supernormal returns are unlikely to last — never mistake it for a fortress.
Margin-of-safety price band
Not a recommendation — the framework’s arithmetic.
- QGLP Price pillar: PEG ≤ 1 is satisfied up to ~40× if you believe ~40% PAT growth persists; the payback test (< 1×) is nowhere close (2.7×). So the QGLP price signal is “okay on near-term growth, expensive on cash payback.”
- Buffett’s Mr. Market read on CMP ₹311: the market is neither fearful nor euphoric — it’s optimistic. You’re paying ~31× trailing / ~20× forward and ~2.5× the multiple of the closest comparable for a narrow-moat, capital-hungry business at what is likely a returns peak.
- The band. On FY27 estimated PAT (~₹430–460 cr, from +50% revenue at 11–13% margin), a 15–18× multiple — appropriate for cyclicality + a narrow moat + a short record — gives ≈ ₹220–₹265 (roughly back at the IPO price). A 20–25× “growth gets the benefit of the doubt” multiple gives ₹293–₹366, i.e. roughly today’s price. So CMP ₹311 already pays for continued flawless execution; the margin-of-safety zone sits ~15–30% below, around ₹220–265. Plainly: a good business at a full price.
Conviction texture
The bull case, at its strongest. A founder-run, three-decade brand with a real Tier-2/3 dealer franchise is riding the single biggest tailwind in Indian energy — rooftop solar — with policy (PM Surya Ghar, ALMM List-II, anti-dumping walls) actively protecting domestic integrated players like it. It just backward-integrated into scarce, high-margin DCR cells, it executes fast and under budget, and it’s doubling capacity. Revenue and profit are compounding at 70–95%, margins are expanding, and on forward earnings (~20×) it isn’t expensive for that growth. If it converts its dealers to grid-tied solar and earns back its plants before the policy rent fades, it’s a multi-year cyclical-growth winner.
The bear case, at its strongest. Strip the boom and you have a capital-hungry assembler with a commodity panel core and a distribution network one-tenth the size of Luminous’s, earning supernormal returns on a temporary domestic-cell shortage that the whole industry is racing to erase — and every mature precedent for this business (Exide, Amara Raja) settled at low-teens ROE, with Su-Kam showing the bankruptcy tail. It consumed cash in its growth years, may be flattering profit by capitalising interest, just had a plant burn down and a BIS seizure, has a 7-month public record and an 87% promoter stake — and trades at ~2.5× its closest twin. The returns you’re underwriting are a peak, not a plateau.
What the numbers actually support: a Good, well-run, genuinely growing business that is creating economic value today — but whose quality is narrower and returns less durable than the headline ROE suggests, at a price that already assumes the good times continue. The three things that tip it: (1) the DCR gross-margin trend (the rent), (2) PM Surya Ghar demand after the June-2026 pause, and (3) operating cash flow finally catching up to reported profit. No buy/sell/hold — the reader decides.
Sources
- Screener snapshot — https://www.screener.in/company/UTLSOLAR/ (note: public financials stale at FY20–21; ratios reconciled against FY26 results + IPO note).
- FY26 / Q4 FY26 results — Business Upturn; ScanX — FY26 PAT ₹3,041m.
- Q3 & 9M FY26 + FY26 earnings-call transcripts (Feb 2026, May 2026), hosted by Motilal Oswal — BSE filings.
- IPO — Business Standard (2.14× subscription); Groww IPO note (use of proceeds, channel breakdown).
- Bawal fire (6 May 2026) — TradingView/Reuters.
- Competitive/policy crux (Luminous/Microtek/Exide reach, ALMM List-II, DCR premium, Mono-PERC vs TOPCon, precedent returns) — internal research sweep, June 2026 (Mercom, pv-magazine, pv-tech, MNRE/PIB, screener peer pages).
- Assumptions: Cost of Equity 12%; PAT CAGR 30% for the payback calc; sustainable ROE ~28% for Economic Profit. Net worth and P/B estimated post-IPO pending the audited FY26 annual report.
- To verify in the FY26 annual report: interest-capitalisation policy; OCF vs PAT; promoter pledging; related-party transactions; exact post-IPO net worth/book value; BIS case status.